Patient Navigation for Colorectal Cancer Screening for Patients With Mental Illness and/or Substance Use Disorder
NCT ID: NCT03244787
Last Updated: 2018-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
380 participants
INTERVENTIONAL
2017-01-31
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Patient Navigation to Promote Colon Cancer Screening
NCT01141114
Improving Comprehensive Cancer Screening Among Vulnerable Patients Using Patient Navigation
NCT02553538
Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients
NCT00582829
Optimizing Navigation to Successful Colorectal Cancer Screening
NCT02192034
Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations
NCT00476970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patient navigation
PN will contact patients during their visits to health cancer or over the phone. During this initial contact, the PN will educate patients about CRC, screening and explore their barriers to screening. The PN will coordinate scheduling of CRC screening and remind patients about the tests. PN will explain preparation for colonoscopy and whenever feasible, accompany patient to obtain the test. Further interventions may include: reminding the patient about the test, helping with translation, insurance issues, transportation, and overcoming any other system barriers as needed.
patient navigation
Current standard of care is for PNs to work with patients from health centers who are referred by providers. Intervention patients will appear on a PN list without any referral by providers. Control high risk patients will proceed normally and will be eligible to transfer to a PN list after the 6-month study period.
usual care
patients randomly assigned to the control will receive usual care and be eligible for navigation after the study period.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
patient navigation
Current standard of care is for PNs to work with patients from health centers who are referred by providers. Intervention patients will appear on a PN list without any referral by providers. Control high risk patients will proceed normally and will be eligible to transfer to a PN list after the 6-month study period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* receive care at MGH Charlestown
* have documented history of MH or SUD in electronic medical record
Exclusion Criteria
* patients with total colectomy
50 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carolina Abuelo
Instructor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sanja Percac Lima, MD
Role: PRINCIPAL_INVESTIGATOR
MGH
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016P001322
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.